Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Bonde

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|September 24, 2024
Discontinuation of cervical cancer screening for HPV-vaccinated women?Jesper Bonde, Anne Hammer
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 26, 2009
High frequency of multiple HPV types in cervical specimens from Danish womenNina Mejlhede, Jesper Bonde, Anders Fomsgaard
Expert Review of Anticancer Therapy|August 3, 2011
Human papillomavirus testing and genotyping in cervical screeningMatejka Rebolj, Elsebeth Lynge, Jesper Bonde
BMC Cancer|April 18, 2015
Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample studyDitte Møller Ejegod, Matejka Rebolj, Jesper Bonde
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 27, 2023
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?Marc Arbyn, Kate Cuschieri, Mario Poljak, et al.
Current Opinion in Hematology|November 19, 2004
Recent advances in hematopoietic stem cell biologyJesper Bonde, David A Hess, Jan A Nolta
Journal of Translational Medicine|September 16, 2022
Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?Marc Arbyn, Jesper Bonde, Kate Cushieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 8, 2025
The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator testAnja Oštrbenk, Helle Pedersen, Mario Poljak, et al.
BMJ (Clinical Research Ed.)|May 25, 2011
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic reviewMatejka Rebolj, Jesper Bonde, Sisse Helle Njor, et al.
Current Protocols in Human Genetics|April 23, 2008
Human hematopoietic cell culture, transduction, and analysesJesper Bonde, Louisa Wirthlin, Donald B Kohn, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Acta Obstetricia Et Gynecologica Scandinavica|September 24, 2024
Discontinuation of cervical cancer screening for HPV-vaccinated women?Jesper Bonde, Anne Hammer
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 26, 2009
High frequency of multiple HPV types in cervical specimens from Danish womenNina Mejlhede, Jesper Bonde, Anders Fomsgaard
Expert Review of Anticancer Therapy|August 3, 2011
Human papillomavirus testing and genotyping in cervical screeningMatejka Rebolj, Elsebeth Lynge, Jesper Bonde
BMC Cancer|April 18, 2015
Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample studyDitte Møller Ejegod, Matejka Rebolj, Jesper Bonde
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 27, 2023
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?Marc Arbyn, Kate Cuschieri, Mario Poljak, et al.
Current Opinion in Hematology|November 19, 2004
Recent advances in hematopoietic stem cell biologyJesper Bonde, David A Hess, Jan A Nolta
Journal of Translational Medicine|September 16, 2022
Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?Marc Arbyn, Jesper Bonde, Kate Cushieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 8, 2025
The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator testAnja Oštrbenk, Helle Pedersen, Mario Poljak, et al.
BMJ (Clinical Research Ed.)|May 25, 2011
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic reviewMatejka Rebolj, Jesper Bonde, Sisse Helle Njor, et al.
Current Protocols in Human Genetics|April 23, 2008
Human hematopoietic cell culture, transduction, and analysesJesper Bonde, Louisa Wirthlin, Donald B Kohn, et al.
Pageof 9